Drugs / Trimethoprim/sulfamethoxazole
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06737016 Background | Nov 2024 → May 2026 overdue | posterior urethral valve | Mansoura University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/sulfamethoxazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06737016 ↗ |
| Known as | TMP/SMZ | “Trimethoprim/sulfamethoxazole (TMP/SMZ)” NCT06737016 ↗ |
| Route | Oral | “Children will be maintained on an oral prophylactic dose of Trimethoprim/sulfamethoxazole” NCT06737016 ↗ |